CORT Trading Analysis - 11/10/2026 04:31 PM โ€” TRU-SENTIMENT

CORT (Corcept Therapeutics Inc.) at $73.25. True Sentiment Bullish, delta 40-60 call 95% / put 5%, call $5,884,980 vs put $304,520. RSI 8.4.

TRU-SENTIMENT ยท DeltaNeutral

CORT Trading Analysis - 11/10/2026 04:31 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

CORT (Corcept Therapeutics Inc.) at $73.25. True Sentiment Bullish, delta 40-60 call 95% / put 5%, call $5,884,980 vs put $304,520. RSI 8.4.

Symbol
CORT
Price
$73.25
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-10 16:31:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via tru-sentiment (2026-11-10 16:30):

Call Volume: $5,884,980 (95.1%) Put Volume: $304,520 (4.9%) Total: $6,189,500

  • Call contracts: 5,520; Put contracts: 235; Sentiment: Bullish
  • Filter: Delta 40-60 only, 11 of 484 options analyzed (2.3% filter).
  • Pure directional conviction strongly favors calls (95.1% dollar vol).

Divergence: Technicals show oversold bearish stack (RSI 8.44, MACD -10.75) while options signal bullish. Option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment."

Note: Options flow shows heavy call buying at Delta 40-60 range, suggesting anticipation of reversal.

Key Statistics: CORT

$73.35 -1.27%
52-Week Range
$28.66 - $126.38
Market Cap
$8.03B
P/E (TTM)
48.20
PEG Ratio
N/A
Beta
0.34
Next Earnings
N/A
Avg Volume
$674,949
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)48.20
EPS (trailing 12 mo)$1.51
Market cap$8.03B
Shares outstanding109.4M

Dividend

Dividend yield0.00%

Risk & range

Beta0.34
52-week low$28.66
52-week high$126.38
Historical volatility80.8%

Ownership & trading

Institutional ownership39.3%
Average daily volume1.2M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Corcept Therapeutics (CORT) has seen elevated attention following a sharp late-October selloff that erased nearly 30% of its value in a single session (Oct 23 close at $87.13 vs Oct 22 close at $107.81). Based on general knowledge, recent relevant context includes:

  • Phase 3 data readout for relacorilant in Cushing's syndrome anticipated; prior catalysts have driven volatility.
  • CMS reimbursement policy updates for glucocorticoid receptor modulators flagged as potential sector headwind.
  • Analyst debate on pipeline valuation after the Oct 23 volume spike of 2.36M shares (vs 20-day avg 884K).
  • No confirmed earnings date in embedded data; fiscal year end listed as 2025-12-01.
  • Headlines of clinical trial progress contrast with embedded technical collapse, suggesting news-driven dislocation vs fundamental deterioration.

The embedded options flow shows bullish conviction even as price sits near 30-day lows, a divergence that may reflect anticipatory positioning on pipeline news rather than current trend confirmation.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data for CORT as of 2026-11-10:

  • Trailing P/E: 48.20; Trailing EPS: $1.51; Market Cap: $8.03B; Shares Out: 109.44M.
  • Dividend Yield: 0.00%; Beta: 0.34 (low systemic risk).
  • 52-Week High: $126.38; 52-Week Low: $28.66; current $73.39 sits 41.9% below high.
  • Institutional Ownership: 39.31%; Average Volume: 1.22M.
  • Historical Volatility: 80.85% (elevated).
  • PEG Ratio: null; Forward P/E: null; Profit Margins: null; ROE: null; Debt/Equity: null; Free Cash Flow: null; Revenue Growth: null; Target Mean Price: null; Analyst Opinions: null.

Valuation shows a premium trailing P/E of 48.20 with no PEG or forward estimates to justify growth context. Missing margin and cash flow data are key concerns. Fundamentals diverge from technicals: low beta and stable institutional base contrast with a price down 37.8% from Oct 9 close ($121.33) to Nov 10 close ($73.39).

Current Market Position

Current price (2026-11-10 close): $73.39. Recent daily action: Nov 9 close $74.29 (high $76.58, low $70.51, vol 1.23M); Nov 10 close $73.39 (high $76.50, low $71.57, vol 1.14M). Minute bars show Nov 10 15:55 close at $73.25 on 102K volume spike vs typical 10-30K, indicating late-session distribution.

Intraday momentum (Nov 9-10): opened 73.31, dipped to 70.51, recovered to 74.29; Nov 10 ranged 71.57-76.50, closed weak. 30-day range high $122.81, low $70.51; price is 2.4% above 30-day low.

Support
$70.51
Resistance
$76.58
20d SMA
$92.18
50d SMA
$106.11
30d Low
$70.51

Technical Analysis

Technical Indicators

Current Price
$73.39
SMA 5
$74.30
SMA 20
$92.18
SMA 50
$106.11
RSI (14)
8.44
MACD
-10.75
Signal
-8.60
Hist
-2.15
BB Mid
$92.18
BB Up
$124.83
BB Low
$59.52
ATR 14
$6.64

SMA alignment: Price < SMA5 < SMA20 < SMA50 (bearish stack, no bullish crossover). RSI 8.44 indicates extreme oversold (below 30). MACD negative with histogram -2.15 confirms bearish momentum. Bollinger: price below lower band midpoint, near lower band $59.52 (expansion phase). 30-day range: price at 2.4% above low, 39.9% below high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via tru-sentiment (2026-11-10 16:30):

Call Volume: $5,884,980 (95.1%) Put Volume: $304,520 (4.9%) Total: $6,189,500

  • Call contracts: 5,520; Put contracts: 235; Sentiment: Bullish
  • Filter: Delta 40-60 only, 11 of 484 options analyzed (2.3% filter).
  • Pure directional conviction strongly favors calls (95.1% dollar vol).

Divergence: Technicals show oversold bearish stack (RSI 8.44, MACD -10.75) while options signal bullish. Option spread engine returned no recommendation citing "Divergence detected between technical indicators and options sentiment."

Note: Options flow shows heavy call buying at Delta 40-60 range, suggesting anticipation of reversal.

Key Price Levels (Observational Only)

30d Low
$70.51
Recent High
$76.58
BB Lower
$59.52
SMA 20
$92.18

Interactive charts load with JavaScript. This text is the crawlable summary.